Cargando…
New treatments and new assessment instruments for Hidradenitis suppurativa
Research interest in Hidradenitis Suppurativa (HS) has grown exponentially over the past decades. Several groups have worked to develop novel scores that address the drawbacks of existing investigator‐assessed and patient‐reported outcome measures currently used in HS trials, clinical practice and r...
Autores principales: | van Straalen, Kelsey R., Ingram, John R., Augustin, Matthias, Zouboulis, Christos C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542859/ https://www.ncbi.nlm.nih.gov/pubmed/35582833 http://dx.doi.org/10.1111/exd.14609 |
Ejemplares similares
-
Cutting edge technologies in chronic inflammation research
por: Laman, Jon D.
Publicado: (2022) -
Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021) -
A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
por: Vossen, A.R.J.V., et al.
Publicado: (2020) -
Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real‐world results from the HARMONY Study
por: Hafner, A., et al.
Publicado: (2021) -
Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
por: Marzano, A.V., et al.
Publicado: (2020)